Compare Kingsoft Cloud Holdings Limited (KC) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kingsoft Cloud Holdings Limited vs Natera Inc. Common Stock — how do they compare? Kingsoft Cloud Holdings Limited trades at $8.56 (market cap $2.77B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 20.6× Kingsoft Cloud Holdings Limited's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kingsoft Cloud Holdings Limited for 12 Days and Natera Inc. Common Stock for 0 Days on average.
| KC | NTRA | |
|---|---|---|
Market Cap | $2.77B | $57.03B |
Volume | 986,009 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $18.21 | $425.64 |
52-Week Low | $8.58 | $179.42 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $3.10B | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kingsoft Cloud (KC) trades at $9.32, up 0.76% with a bearish technical signal despite recent earnings beats. The company shows improving revenue trends ($11.0B projected for 2026) and significant AI cloud growth, though profitability remains negative with -5.46% net margin. Analyst sentiment is strongly positive with 70% buy ratings and 60.25% upside potential cited.
KC presents a high-risk, high-reward opportunity with strong AI-driven growth potential but persistent profitability challenges. The stock's appeal hinges on continued AI cloud expansion and margin improvement, though investors face execution risks and Chinese regulatory exposure. Wall Street optimism contrasts with current technical weakness.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
